SCHEMBL26587296

SCHEMBL26587296

C=CC(=O)N1CCC2(CC=C(c3c(-c4ccc(Oc5ncccn5)cc4)c4c(N)ncnc4n3C)CC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 18/20 0.47
▸ EGFR P00533 3/20 0.43
▸ BLK P51451 2/20 0.41
▸ TEC P42680 2/20 0.41
▸ BMX P51813 2/20 0.41
▸ ITK Q08881 2/20 0.41
▸ ERBB4 Q15303 2/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ RET P07949 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ TXK P42681 1/20 0.41
▸ FGFR2 P21802 1/20 0.41
▸ KCNH2 Q12809 2/20 0.40
▸ FGFR1 P11362 1/20 0.40
▸ FGFR4 P22455 1/20 0.40
▸ CD69 Q07108 1/20 0.40
▸ GP6 Q9HCN6 1/20 0.40
▸ NUDT5 Q9UKK9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30582498 0.97 BTK (0.50) BTKEGFRBLKTECBMX
SCHEMBL26587174 0.93 BTK (0.47) BTKEGFRBLKTECBMX
SCHEMBL26587446 0.90 FGFR2 (0.50) BTKITKFGFR2FGFR1FGFR4
SCHEMBL26108691 0.88 SRC (0.41) BTKEGFRRET
SCHEMBL30582586 0.88 SRC (0.41) BTKEGFRRET
SCHEMBL26587732 0.88 BTK (0.44) BTKEGFRITKFGFR2FGFR1
SCHEMBL26587704 0.88 FGFR4 (0.44) BTKEGFRITKFGFR2FGFR1
SCHEMBL22673393 0.87 BTK (0.49) BTKEGFRBLKTECBMX
SCHEMBL26587541 0.87 FGFR1 (0.47) BTKEGFRBLKFGFR2FGFR1
SCHEMBL26588196 0.86 NUDT14 (0.39) BTKFGFR2FGFR1FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP claimed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN claimed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO claimed
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback